(Crain?s) ? Despite a hefty 17% increase in first-quarter sales, Abbott Laboratories Inc.?s stock price remained stuck in place Wednesday, possibly amid concerns about slipping profit margins. The North Chicago-based pharmaceutical company said its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Profit-margin worries for Abbott
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account